SCHEMBL20174302

SCHEMBL20174302

c1ccc2c(c1)-c1ccc(-c3ccc4ccc5cccnc5c4n3)cc1C21c2ccccc2-c2oc3ccccc3c21

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.34
MAPT P10636 3/20 0.34
HPGD P15428 2/20 0.34
HSD17B10 Q99714 2/20 0.34
ALDH1A1 P00352 1/20 0.34
GAA P10253 1/20 0.34
L3MBTL1 Q9Y468 3/20 0.33
TSHR P16473 2/20 0.33
RAB9A P51151 1/20 0.33
PDK2 Q15119 1/20 0.33
PDE4D Q08499 2/20 0.32
LMNA P02545 2/20 0.32
GMNN O75496 1/20 0.32
TP53 P04637 1/20 0.32
HSP90AA1 P07900 1/20 0.32
MMP2 P08253 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
MMP9 P14780 1/20 0.32
ALOX15 P16050 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20174332 0.91 KDM4E (0.36) KDM4EMAPTHPGDHSD17B10ALDH1A1
SCHEMBL20174341 0.89 KDM4E (0.35) KDM4EMAPTHPGDHSD17B10ALDH1A1
SCHEMBL18590023 0.87 KDM4E (0.34) KDM4EMAPTHPGDHSD17B10ALDH1A1
SCHEMBL20174319 0.85 KDM4E (0.36) KDM4EMAPTHPGDHSD17B10ALDH1A1
SCHEMBL20174282 0.84 KDM4E (0.38) KDM4EMAPTHPGDHSD17B10ALDH1A1
SCHEMBL20174429 0.84 GRM4 (0.34) KDM4EMAPTHPGDHSD17B10ALDH1A1
SCHEMBL11962213 0.82 CCR1 (0.44) KDM4EMAPTHSD17B10ALDH1A1L3MBTL1
SCHEMBL12708774 0.82 CCR1 (0.44) KDM4EMAPTHSD17B10ALDH1A1L3MBTL1
SCHEMBL15944519 0.82 CCR1 (0.44) KDM4EMAPTHSD17B10ALDH1A1L3MBTL1
SCHEMBL18590027 0.82 BACE1 (0.34) KDM4EMAPTHPGDHSD17B10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10738034-B2 Spiro compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2020-08-11 US disclosed
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10738034-B2 Spiro compound and organic light-emitting device comprising same CRY1, NR2E3, ERG KDM4E 3633/4885MAPT 811/4885HPGD 2229/4885
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, NR2E3, ERG KDM4E 3633/4885MAPT 811/4885HPGD 2229/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.